Table 5

Comparison between repair and prosthesis groups

RepairProsthesisP value
Age (years)64.36±11.764.87±6.70.86
Body mass index (kg/m2)28.4861±4.7827.49±4.340.75
SPAP (mm Hg)55.35±16.8139.58±10.510.02
Glomerular filtration rate
(mL/kg/min)
74.25±18.3873.68±19.030.92
EuroSCORE (%)6.19±13.334.36±2.460.31
Extracorporeal time (min)115.59±39.1388.14±37.790.08
Clamping time (min)96.89±36.2237.55±48.690.01
Sex (female) (%)75.8800.49
Arterial hypertension (%)54.826.70.02
Previous stroke (%)12.76.70.37
Ischaemic heart disease (%)9.76.70.12
Atrial fibrillation (%)7993.30.02
NYHA functional class (%)
 II
 III
53.2
37.1
33.3
46.7
0.03
Right heart failure (%)43.533.30.32
LVEF (%)
 Normal
 Mild
 Moderate
85.5
12.9
1.6
93.3
6.7
0.67
Death during hospital stay3.8110.27
Pacemaker implantation during first year of follow-up14.3200.07
Death during first year of follow-up6120.47
RVEF (%)
 Normal
 Mild
 Moderate
82.3
14.5
3.2
60
40
0.02
TR aetiology (%)
 Functional
 Rheumatic
76.7
20
53.3
40
0.6
Echocardiography
Basal diameter RV (mm)47.7±7.3956.33±5.740.01
Mid-diameter RV (mm)36.8±8.4943.33±6.80.01
Shortening fraction (%)39.71±13.6739.42±16.060.94
TAPSE (mm)19.64±5.0218.07±2.640.15
Longitudinal strain (%)−20.39±5.25−17.52±2.870.05
Vena contracta (mm)6.8±5.2011.3 (1.92)0.09
PISA radius (mm)8.57±2.648.25 (3.57)0.76
Regurgitant orifice (cm2)0.4 (0.57)0.8 (0.23)0.01
Regurgitating volume (mL)40.43±22.0458.33 (34.8)0.03
Tenting area (cm2)1.41±1.213.5 (3.57)0.06
Coaptation distance (mm)6.9±3.316.1 (21.4)0.01
  • LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PISA, proximal isovelocity surface area; RV, right ventricle; RVEF, right ventricular ejection fraction; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.